Gadovist 1.0mmol/ml (Vials)
Last Updated on eMC 22-May-2017 View document | Bayer plc Contact details
Versions
- 22-May-2017 to Current
- 03-Aug-2015 to 22-May-2017
- 20-Jul-2015 to 03-Aug-2015
- 10-Nov-2014 to 20-Jul-2015
- 13-Mar-2014 to 10-Nov-2014
- 12-Mar-2014 to 13-Mar-2014
- 05-Dec-2013 to 12-Mar-2014
- 23-Nov-2012 to 05-Dec-2013
- 30-Mar-2012 to 23-Nov-2012
- 06-Feb-2012 to 30-Mar-2012
- 01-Aug-2011 to 06-Feb-2012
- 26-Oct-2010 to 01-Aug-2011
- 18-Dec-2009 to 26-Oct-2010
- 23-Sep-2009 to 18-Dec-2009
- 23-Feb-2009 to 23-Sep-2009
- 20-May-2008 to 23-Feb-2009
- 14-Aug-2007 to 20-May-2008
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 22-May-2017 and displayed until Current
Reasons for adding or updating:
- Change to section 6 - manufacturer
- Change to section 6 - date of revision
Updated on 03-Aug-2015 and displayed until 22-May-2017
Reasons for adding or updating:
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 2 - use in children/adolescents
- Change to section 3 - dose and frequency
- Change to section 3 - use in children/adolescents
- Change to section 4 - possible side effects
Updated on 20-Jul-2015 and displayed until 03-Aug-2015
Reasons for adding or updating:
- Change to section 3 - how to take/use
Updated on 10-Nov-2014 and displayed until 20-Jul-2015
Reasons for adding or updating:
- Change to section 4 - how to report a side effect
- Change to section 6 - date of revision
Updated on 13-Mar-2014 and displayed until 10-Nov-2014
Reasons for adding or updating:
- Removal of black triangle
Updated on 12-Mar-2014 and displayed until 13-Mar-2014
Reasons for adding or updating:
- Change to section 6 - what the product contains
- Change to section 6 - what the product looks like and pack contents
Updated on 05-Dec-2013 and displayed until 12-Mar-2014
Reasons for adding or updating:
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 2 - pregnancy, breast feeding and fertility
- Change to section 4 - possible side effects
Updated on 23-Nov-2012 and displayed until 05-Dec-2013
Reasons for adding or updating:
- Change to date of revision
Updated on 30-Mar-2012 and displayed until 23-Nov-2012
Reasons for adding or updating:
- Change to Further Information section
- Change to date of revision
- Change to, or new, use for medicine
Updated on 06-Feb-2012 and displayed until 30-Mar-2012
Reasons for adding or updating:
- Change to date of revision
Updated on 01-Aug-2011 and displayed until 06-Feb-2012
Reasons for adding or updating:
- Change to date of revision
- Change to manufacturer contact details
Updated on 26-Oct-2010 and displayed until 01-Aug-2011
Reasons for adding or updating:
- Change to information for healthcare professionals
- Change to Further Information section
- Change to date of revision
- Change to warnings or special precautions for use
- Change to instructions about overdose
- Change to storage instructions
- Change to side-effects
- Change to information about pregnancy or lactation
Updated on 18-Dec-2009 and displayed until 26-Oct-2010
Reasons for adding or updating:
- Change to date of revision
- Change to side-effects
Updated on 23-Sep-2009 and displayed until 18-Dec-2009
Reasons for adding or updating:
- Change to date of revision
- Change to, or new, use for medicine
- Extra statutory information
Updated on 23-Feb-2009 and displayed until 23-Sep-2009
Reasons for adding or updating:
- Change to Further Information section
- Change to date of revision
- Change to side-effects
Updated on 20-May-2008 and displayed until 23-Feb-2009
Reasons for adding or updating:
- Change to date of revision
- Change to Marketing Authorisation Holder
- Change to MA holder contact details
Updated on 14-Aug-2007 and displayed until 20-May-2008
Reasons for adding or updating:
- Addition of separate PILs covering individual presentations
Bayer plc
Bayer House, Strawberry Hill, Newbury, Berkshire, RG14 1JA
+44 (0)1635 563 393
+44 (0)1635 563 000
Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Active ingredients
Legal categories
This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue